Research ArticleOncology
Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
Garry Ceccon, Philipp Lohmann, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Niklas Schäfer, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks
Journal of Nuclear Medicine July 2021, 62 (7) 918-925; DOI: https://doi.org/10.2967/jnumed.120.254243
Garry Ceccon
1Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany;
Philipp Lohmann
2Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany;
Jan-Michael Werner
1Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany;
Caroline Tscherpel
1Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany;
2Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany;
Veronika Dunkl
1Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany;
Gabriele Stoffels
2Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany;
Jurij Rosen
1Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany;
Marion Rapp
3Department of Neurosurgery, University Hospital Duesseldorf, Duesseldorf, Germany;
Michael Sabel
3Department of Neurosurgery, University Hospital Duesseldorf, Duesseldorf, Germany;
Ulrich Herrlinger
4Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, Germany;
5Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Aachen and Cologne, Germany;
Niklas Schäfer
4Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, Germany;
5Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Aachen and Cologne, Germany;
Nadim J. Shah
2Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany;
6Department of Neurology, University Hospital Aachen, Aachen, Germany; and
Gereon R. Fink
1Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany;
2Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany;
Karl-Josef Langen
2Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany;
5Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Aachen and Cologne, Germany;
7Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany
Norbert Galldiks
1Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany;
2Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany;
5Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Aachen and Cologne, Germany;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 7
July 1, 2021
Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
Garry Ceccon, Philipp Lohmann, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Niklas Schäfer, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen, Norbert Galldiks
Journal of Nuclear Medicine Jul 2021, 62 (7) 918-925; DOI: 10.2967/jnumed.120.254243
Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
Garry Ceccon, Philipp Lohmann, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Niklas Schäfer, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen, Norbert Galldiks
Journal of Nuclear Medicine Jul 2021, 62 (7) 918-925; DOI: 10.2967/jnumed.120.254243